Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group

Lancet. 1998 May 9;351(9113):1404. doi: 10.1016/s0140-6736(05)79442-3.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Contraceptives, Oral, Synthetic / adverse effects*
  • Desogestrel / adverse effects
  • Female
  • Humans
  • Middle Aged
  • Netherlands / epidemiology
  • Norpregnenes / adverse effects
  • Risk Factors
  • Sinus Thrombosis, Intracranial / chemically induced*
  • Sinus Thrombosis, Intracranial / epidemiology

Substances

  • Contraceptives, Oral, Synthetic
  • Norpregnenes
  • Gestodene
  • Desogestrel